Funding for this research was provided by:
National Center for Advancing Translational Sciences (UL1 TR001860 linked award TL1 TR001861)
LiquidGoldConcept, Inc. (N/A)
Received: 17 June 2019
Accepted: 4 February 2020
First Online: 17 February 2020
Ethics approval and consent to participate
: User-testing was approved by the University of Michigan IRB (HUM00125612, HUM00148905, HUM00148728.
: Not Applicable.
: LiquidGoldConcept, Inc. (LGC) was the study sponsor and is the manufacturer of the LSM. LGC was involved in the study design and execution, data analysis, and manuscript writing. AS is the President, Chief Executive Officer, and shareholder of LGC. JSP is the Vice-President, Chief Technology Officer, and shareholder of LGC. SAC is the Chief Operating Officer and employee of LGC and has received stock options from LGC. KM is a statistical consultant at LGC and has received stock options.